Catalyst Wire Dossier Catalyst Wire Dossier

Spikevax (mRNA-1273) vaccine

mRNA-1273 · ModernaTX, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Spikevax (mRNA-1273) vaccine, covering 2024-06-18 to 2024-06-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants [Phase 3]

See pricing